» Articles » PMID: 33922578

Why Did ZIKV Perinatal Outcomes Differ in Distinct Regions of Brazil? An Exploratory Study of Two Cohorts

Abstract

The Zika virus (ZIKV) epidemic in Brazil occurred in regions where dengue viruses (DENV) are historically endemic. We investigated the differences in adverse pregnancy/infant outcomes in two cohorts comprising 114 pregnant women with PCR-confirmed ZIKV infection in Rio de Janeiro, Southeastern Brazil ( = 50) and Manaus, in the north region of the country ( = 64). Prior exposure to DENV was evaluated through plaque reduction neutralizing antibody assays (PRNT 80) and DENV IgG serologies. Potential associations between pregnancy outcomes and Zika attack rates in the two cities were explored. Overall, 31 women (27%) had adverse pregnancy/infant outcomes, 27 in Rio (54%) and 4 in Manaus (6%), < 0.001. This included 4 pregnancy losses (13%) and 27 infants with abnormalities at birth (24%). A total of 93 women (82%) had evidence of prior DENV exposure, 45 in Rio (90%) and 48 in Manaus (75%). Zika attack rates differed; the rate in Rio was 10.28 cases/10,000 and in Manaus, 0.6 cases/10,000, < 0.001. Only Zika attack rates (Odds Ratio: 17.6, 95% Confidence Interval 5.6-55.9, < 0.001) and infection in the first trimester of pregnancy (OR: 4.26, 95% CI 1.4-12.9, = 0.011) were associated with adverse pregnancy and infant outcomes. Pre-existing immunity to DENV was not associated with outcomes (normal or abnormal) in patients with ZIKV infection during pregnancy.

Citing Articles

Does the Presence or a High Titer of Yellow Fever Virus Antibodies Interfere with Pregnancy Outcomes in Women with Zika Virus Infection?.

Piauilino I, Souza R, Lima M, Rodrigues Y, da Silva L, Gouveia A Viruses. 2023; 15(11).

PMID: 38005922 PMC: 10675107. DOI: 10.3390/v15112244.


Cohort-profile: Household transmission of SARS-CoV-2 in a low-resource community in Rio de Janeiro, Brazil.

Brasil P, Damasceno L, Fuller T, Bastos L, Cruz O, Medeiros F BMJ Open. 2023; 12(12):e067212.

PMID: 36600372 PMC: 9729844. DOI: 10.1136/bmjopen-2022-067212.


Incidence of SARS-CoV-2 over four epidemic waves in a low-resource community in Rio de Janeiro, Brazil: A prospective cohort study.

Carvalho M, Soares Bastos L, Fuller T, Cruz O, Damasceno L, Calvet G Lancet Reg Health Am. 2022; 12:100283.

PMID: 35663637 PMC: 9135359. DOI: 10.1016/j.lana.2022.100283.


Evidence of co-circulation of multiple arboviruses transmitted by Aedes species based on laboratory syndromic surveillance at a health unit in a slum of the Federal District, Brazil.

Rufalco-Moutinho P, de Noronha L, de Souza Cardoso Quintao T, Nobre T, Cardoso A, Ciliao-Alves D Parasit Vectors. 2021; 14(1):610.

PMID: 34924014 PMC: 8684590. DOI: 10.1186/s13071-021-05110-9.

References
1.
Braga J, Bressan C, Dalvi A, Amaral Calvet G, Daumas R, Rodrigues N . Accuracy of Zika virus disease case definition during simultaneous Dengue and Chikungunya epidemics. PLoS One. 2017; 12(6):e0179725. PMC: 5484469. DOI: 10.1371/journal.pone.0179725. View

2.
Halstead S . Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies. Emerg Infect Dis. 2017; 23(4):569-573. PMC: 5367429. DOI: 10.3201/eid2304.161879. View

3.
Nogueira M, Nery Junior N, Estofolete C, Bernardes Terzian A, Guimaraes G, Zini N . Adverse birth outcomes associated with Zika virus exposure during pregnancy in São José do Rio Preto, Brazil. Clin Microbiol Infect. 2017; 24(6):646-652. DOI: 10.1016/j.cmi.2017.11.004. View

4.
McCracken M, Gromowski G, Friberg H, Lin X, Abbink P, de La Barrera R . Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques. PLoS Pathog. 2017; 13(8):e1006487. PMC: 5542404. DOI: 10.1371/journal.ppat.1006487. View

5.
Regla-Nava J, Elong Ngono A, Viramontes K, Huynh A, Wang Y, Nguyen A . Cross-reactive Dengue virus-specific CD8 T cells protect against Zika virus during pregnancy. Nat Commun. 2018; 9(1):3042. PMC: 6072705. DOI: 10.1038/s41467-018-05458-0. View